US Biopharma Geron to use IntelliCASE
for Clinical Pharmacovigilance reporting.
The innovative mobile app, which converts natural language into text, will allow clinical trial participants of any nationality to record any adverse effects directly into a PV database, while retaining full visibility for study controllers.
The benefits of using Veeva Vault Safety, for us, it means that we are able to use their reporting capabilities directly from the safety database. We are able to use the gateway connection with the regulatory authorities and with partners.
Arriello, a global expert in pharmacovigilance consulting and life science outsourcing services, has today announced that Geron Corporation has chosen IntelliCASE as a mobile data capture solution for pharmacovigilance.